Skip to main content
Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News FAQ
On This Report

Veterinary Glucose Monitoring Devices Market Size & Growth Forecast 2027–2036, By Segments (Distribution Channel, Product, Animal Type, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 14142| Published Date: Sep-2026| Format: PDF, Excel
Market Outlook

Market Size and Growth Outlook

Veterinary Glucose Monitoring Devices Market size was worth USD 856.6 million in 2026 and is expected to grow at a 7.22% CAGR between 2027 and 2036, surpassing USD 1.72 billion by 2036. The industry revenue for 2027 is assessed at USD 908.68 million.

Base Year Value (2026)
USD 856.6 million
CAGR (2027-2036)
7.22%
Forecast Year Value (2036)
USD 1.72 billion
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
Snapshot

Veterinary Glucose Monitoring Devices Market Intelligence Snapshot

Regional Market Dynamics

  • North America held a 43.24% market share in 2026, supported by advanced companion animal care, widespread diabetes monitoring practices, and strong adoption of veterinary diagnostic technologies.
  • Asia Pacific is expected to grow at an 8.59% CAGR due to rising pet ownership, improving veterinary services, and increasing demand for long-term glucose monitoring in companion animals.

Segment Momentum

  • Offline stores lead because veterinary clinics, hospitals, and pet owners value immediate product availability, trusted guidance, and support with device selection, strip compatibility, and proper usage.
  • CGMs are the fastest-growing product segment because they provide continuous glucose trend data, enabling closer monitoring and better-informed treatment adjustments than single-point glucose meter readings.

Market Expansion Drivers

  • Rising prevalence of diabetes in companion animals driving demand for continuous glucose monitoring solutions.
  • Growth in pet adoption and humanization of pets increasing preventive chronic disease management spending.
  • Expansion of e-commerce veterinary supply channels improving accessibility of pet diabetes monitoring devices.

Leading Market Participants

  • Leading companies in the veterinary glucose monitoring devices market include Zoetis Inc. (United States), IDEXX Laboratories, Inc. (United States), ACON Laboratories, Inc. (United States), i-SENS, Inc. (South Korea), TaiDoc Technology Corporation (Taiwan), Trividia Health, Inc. (United States), UltiMed, Inc. (United States), Allison Medical, Inc. (United States), Teco Diagnostics (United States), Woodley Equipment Company Ltd. (United Kingdom).

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 856.6 million
  • 2027 Estimated Market Size: USD 908.68 million.
  • Projected Market Size: USD 1.72 billion by 2036
  • Growth Forecast: 7.22% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Offline Stores (Distribution Channel) | Glucose Meters (Product) | Dogs (Animal Type) | Veterinary Hospitals & Clinics (End-use)
  • Emerging Opportunity Segment: Online Stores (Distribution Channel) | Continuous Glucose Monitors (CGMs) (Product) | Cats (Animal Type) | Home Care Settings (End-use)
Market Dynamics

Market Growth Drivers and Industry Trends

Rising prevalence of diabetes in companion animals driving demand for continuous glucose monitoring solutions

Increasing recognition of diabetes among companion animals is creating greater demand for reliable glucose measurement and monitoring technologies, which will drive the veterinary glucose monitoring devices market as veterinarians and pet owners seek more effective ways to manage chronic conditions. Continuous monitoring solutions can provide frequent glucose information without requiring repeated conventional measurements, helping veterinary professionals assess fluctuations and adjust treatment strategies more efficiently. The growing emphasis on early detection, ongoing disease management, and improved quality of life is also encouraging greater adoption of monitoring technologies for animals requiring regular glucose assessment.

Growth in pet adoption and humanization of pets increasing preventive chronic disease management spending

Rising pet ownership and the increasing tendency to treat companion animals as family members are encouraging owners to spend more on preventive healthcare, diagnostics, and long-term disease management, supporting demand within the veterinary glucose monitoring devices market. Pet humanization has increased expectations for sophisticated veterinary care, particularly for chronic conditions that require regular observation and treatment adjustment. As owners become more willing to invest in technologies that improve monitoring convenience and provide veterinarians with more consistent health information, glucose monitoring devices are gaining relevance in routine diabetes management and individualized veterinary care.

Expansion of e-commerce veterinary supply channels improving accessibility of pet diabetes monitoring devices

The expansion of online veterinary supply channels is making specialized monitoring equipment more accessible to pet owners and veterinary professionals, helping boost the veterinary glucose monitoring devices market by reducing barriers associated with product availability. E-commerce platforms can provide broader access to glucose monitoring devices and related supplies, particularly for owners managing chronic conditions that require recurring equipment or replacement components. Online purchasing also supports greater product visibility and facilitates convenient replenishment, while digital access to specialized veterinary supplies can complement clinical consultations and ongoing home-based monitoring practices.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising prevalence of diabetes in companion animals driving demand for continuous glucose monitoring solutions 2.20% Moderate North America, Europe High Near Term
Growth in pet adoption and humanization of pets increasing preventive chronic disease management spending 2.00% Low North America, Asia Pacific High Near Term
Expansion of e-commerce veterinary supply channels improving accessibility of pet diabetes monitoring devices 1.60% Low North America, Europe, Asia Pacific Medium Near Term
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Regional Forecast

Regional Demand Dynamics

Veterinary Glucose Monitoring Devices Market
Largest Region
North America
43.24% Market Share in 2026

North America (Largest Region)

North America dominated the veterinary glucose monitoring devices market in 2026, representing a 43.24% share, supported by advanced veterinary healthcare infrastructure and growing attention to chronic metabolic conditions in companion animals. Veterinary professionals increasingly rely on glucose monitoring to support diagnosis, treatment management, and ongoing assessment of animals requiring metabolic care. Strong pet ownership, greater willingness to spend on specialized veterinary services, and increasing awareness of preventive animal healthcare are contributing to demand for reliable monitoring technologies. The region also benefits from broader adoption of digital and minimally invasive diagnostic solutions, including devices that can facilitate more convenient monitoring outside conventional clinical settings. These factors, combined with established veterinary practices and increasing emphasis on individualized animal care, reinforce North America's leading market position.

Asia Pacific (Fastest-Growing Region)

Asia Pacific is the fastest-growing region, supported by rising companion animal ownership, improving veterinary infrastructure, and increasing awareness of animal health management. As pet owners become more attentive to preventive care and chronic disease monitoring, demand for diagnostic devices that enable timely assessment of glucose levels is expanding. Growth in veterinary clinics and specialized animal healthcare services is also improving access to monitoring technologies across developing markets. At the same time, urbanization and changing household attitudes toward companion animals are encouraging greater expenditure on veterinary treatment and long-term wellness. Increasing availability of technologically advanced diagnostic devices and broader adoption of modern veterinary practices are creating favorable conditions for sustained market growth in the region.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
Country Insights

Key Country Insights

Germany 🇩🇪

Precision Veterinary Monitoring

Germany emphasizes accurate and clinically validated veterinary glucose monitoring systems for long-term disease management in pets. German veterinary providers are adopting advanced monitoring devices that support data-driven treatment decisions and preventive animal healthcare services.

France 🇫🇷

Preventive Animal Health Focus

France is integrating veterinary glucose monitoring devices into broader preventive care and chronic disease management programs for companion animals. French veterinarians are encouraging regular monitoring practices and the use of connected technologies to improve treatment outcomes.

Italy 🇮🇹

Expanding Companion Care Services

Italy's veterinary glucose monitoring devices market is supported by growing awareness of diabetes management in pets and improving veterinary services. Italian clinics are gradually incorporating modern monitoring technologies to provide more personalized and continuous care for animals.

Japan 🇯🇵

Companion Animal Care Innovation

Japan's veterinary glucose monitoring devices market is expanding alongside increasing demand for sophisticated pet healthcare services. Veterinary clinics in Japan are adopting compact and user-friendly monitoring technologies that enable more frequent glucose assessment and owner engagement.

South Korea 🇰🇷

Premium Pet Diagnostics Demand

South Korea is experiencing stronger demand for veterinary glucose monitoring devices as pet owners increasingly seek advanced healthcare solutions. Clinics and pet care providers are introducing digital monitoring systems that support early intervention and long-term diabetes management.

United States 🇺🇸

Connected Pet Health Solutions

The U.S. veterinary glucose monitoring devices market is benefiting from rising adoption of digital tools for managing chronic conditions in companion animals. Veterinary practices in the U.S. are increasingly using continuous monitoring technologies that improve diabetes management and remote care capabilities.

Segment Analysis

Segment Leadership and Growth Trends

Veterinary Glucose Monitoring Devices Market Share (%), by Distribution Channel, 2026

Offline Stores
Online Stores

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Distribution Channel Segment Analysis: Offline Stores (Largest Segment) vs Online Stores (Fastest-Growing Segment)

Offline stores held the largest share of the veterinary glucose monitoring devices market in 2026, supported by the continued importance of physical veterinary pharmacies, clinics, specialty stores, and animal healthcare outlets in the purchase of diagnostic devices. Veterinary professionals and pet owners often value the ability to assess device suitability, receive product guidance, and access immediate support when selecting glucose monitoring equipment. The established presence of offline channels also facilitates professional recommendations and repeat purchases of monitoring accessories and supplies. As awareness of diabetes management in companion animals increases, trusted in-person distribution networks continue to play a central role in device accessibility.

Online stores represent the fastest-growing distribution channel, benefiting from increasing digital adoption among pet owners and veterinary customers seeking convenient access to animal healthcare products. E-commerce platforms provide broader product availability, simplified purchasing, and the ability to compare device features before making a selection. Greater consumer familiarity with online veterinary and pet-care shopping is also supporting this shift, particularly as owners become more proactive about managing chronic conditions at home. Improved digital ordering experiences and the expanding availability of specialized veterinary products are further strengthening the role of online channels.

Product Segment Analysis: Glucose Meters (Largest Segment) vs Continuous Glucose Monitors (CGMs) (Fastest-Growing Segment)

Glucose meters accounted for the largest share of the veterinary glucose monitoring devices market in 2026, reflecting their established role in routine blood glucose assessment for animals requiring diabetes management. These devices offer practical measurement capabilities and are widely suited to veterinary monitoring practices as well as at-home testing under professional guidance. Their relatively straightforward operation and familiarity among veterinary professionals support continued adoption, while the growing need for regular glucose assessment in diabetic animals reinforces demand for conventional monitoring solutions.

Continuous glucose monitors (CGMs) are the fastest-growing product segment as veterinary care increasingly adopts technologies that provide more comprehensive and less intermittent glucose monitoring. CGMs can support continuous tracking of glucose patterns, helping veterinarians and pet owners better understand fluctuations and evaluate treatment responses. Their growing relevance is linked to the broader movement toward data-driven animal healthcare, remote monitoring, and improved management of chronic conditions. As veterinary practices and pet owners place greater emphasis on ongoing disease monitoring and more informed treatment decisions, CGMs are gaining traction as an advanced alternative to conventional measurement approaches.

Segment Sub-Segment Largest Segment Fastest Growing
Distribution Channel Online Stores, Offline Stores Offline Stores Online Stores
Product Glucose Meters, Continuous Glucose Monitors (CGMs), Veterinary Blood Analyzer, Consumables Glucose Meters Continuous Glucose Monitors (CGMs)
Animal Type Dogs, Cats, Horses, Others Dogs Cats
End-use Veterinary Hospitals & Clinics, Home Care Settings, Veterinary Diagnostic Centers, Others Veterinary Hospitals & Clinics Home Care Settings
Read our Research Approach →
Competitive Landscape

Competitive Landscape and Market Positioning

Major players in the veterinary glucose monitoring devices market:

1. Zoetis Inc. (United States)

2. IDEXX Laboratories Inc. (United States)

3. ACON Laboratories Inc. (United States)

4. i-SENS Inc. (South Korea)

5. TaiDoc Technology Corporation (Taiwan)

6. Trividia Health Inc. (United States)

7. UltiMed Inc. (United States)

8. Allison Medical Inc. (United States)

9. Teco Diagnostics (United States)

10. Woodley Equipment Company Ltd. (United Kingdom)

Increasing focus on animal health monitoring is driving adoption of smart diagnostic tools in the veterinary glucose monitoring devices market. In the veterinary glucose monitoring devices market, compact and accurate monitoring solutions are improving clinical decision-making.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
Zoetis Inc. (United States)
IDEXX Laboratories Inc. (United States)
ACON Laboratories Inc. (United States)
i-SENS Inc. (South Korea)
TaiDoc Technology Corporation (Taiwan)
Trividia Health Inc. (United States)
UltiMed Inc. (United States)
Allison Medical Inc. (United States)
Teco Diagnostics (United States)
Woodley Equipment Company Ltd. (United Kingdom).
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
ALR Technologies SG Ltd. Aug-23 ALR Technologies SG Ltd. planned the launch of GluCurve Pet CGM in Canada, targeting veterinary clinics through direct sales channels. The initiative expands access to continuous glucose monitoring solutions for companion animals and supports adoption of digital diabetes management tools within veterinary care networks.
Zoetis Feb-23 Zoetis launched the AlphaTrak 3 blood glucose monitoring system for cats and dogs in the U.S., featuring integrated mobile app connectivity for real-time data sharing between pet owners and veterinarians. The product strengthens Zoetis’ companion animal diabetes management portfolio and expands digital-enabled veterinary diagnostic capabilities.
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Veterinary Glucose Monitoring Devices Market — Custom Segments

Segment Sub-Segment
Clinical Use Case Diabetes Diagnosis, Routine Glucose Monitoring, Intensive Glycemic Monitoring
Connectivity Non-Connected Devices, Bluetooth-Enabled Devices, Cloud-Connected Devices
Procurement Model Capital Equipment Purchase, Reagent & Consumables-Based Purchase, Subscription & Rental Models

Veterinary Glucose Monitoring Devices Market — Custom TOC

Custom Chapter Custom Details
Companion Animal Diabetes Care Adoption Analysis
  • Diabetes Prevalence and Diagnosis Trends in Companion Animals
  • Glucose Monitoring Practices Across Veterinary Care
  • Device Adoption Drivers and Clinical Use Cases
  • Monitoring Frequency and Home-Care Trends
  • Barriers to Wider Diabetes Monitoring Adoption
Connected Veterinary Monitoring Ecosystem
  • Connected Glucose Monitoring Use Cases
  • Device-to-Clinic Data Connectivity
  • Remote Monitoring and Veterinary Decision Support
  • Integration With Digital Veterinary Platforms
  • Ecosystem Development and Technology Priorities
Veterinary Clinic Purchasing Behavior Assessment
  • Device Selection Criteria Across Veterinary Practices
  • Clinical Workflow and Usability Requirements
  • Procurement Decision-Makers and Purchasing Processes
  • Cost, Reliability, and Service Considerations
  • Adoption Priorities Across Veterinary Practice Types

Need a different cut of the data?

Request Custom Research
Frequently Asked Questions

How big is the veterinary glucose monitoring devices market?

The market revenue for veterinary glucose monitoring devices is anticipated at USD 908.68 million in 2027.

How will the veterinary glucose monitoring devices industry grow in terms of size and CAGR by 2036?

Veterinary Glucose Monitoring Devices Market size was worth USD 856.6 million in 2026 and is expected to grow at a 7.22% CAGR between 2027 and 2036, surpassing USD 1.72 billion by 2036.

How is the shift toward continuous glucose monitoring changing diabetes management in veterinary care?

Continuous glucose monitoring is improving veterinary diabetes management by providing real-time glucose trends instead of isolated readings. This supports more accurate insulin adjustments and reduces reliance on stress-influenced clinic-based measurements, improving treatment consistency for companion animals.

What is driving the growing shift toward online purchasing of veterinary glucose monitoring devices and supplies?

Online channels are expanding as pet owners increasingly prefer convenient access to recurring supplies like sensors and strips. The ease of repeat purchasing and home delivery is making digital platforms more attractive than traditional offline procurement for long-term disease management.

Why do offline stores hold the largest share of the veterinary glucose monitoring devices market?

Offline stores lead because veterinary clinics, hospitals, and pet owners value immediate product availability, trusted guidance, and support with device selection, strip compatibility, and proper usage.

What is driving the growth of continuous glucose monitors (CGMs) in the veterinary glucose monitoring devices market?

CGMs are the fastest-growing product segment because they provide continuous glucose trend data, enabling closer monitoring and better-informed treatment adjustments than single-point glucose meter readings.

Why does North America dominate the veterinary glucose monitoring devices market?

North America held a 43.24% market share in 2026, supported by advanced companion animal care, widespread diabetes monitoring practices, and strong adoption of veterinary diagnostic technologies.

What is fueling growth in the Asia Pacific veterinary glucose monitoring devices market?

Asia Pacific is expected to grow at an 8.59% CAGR due to rising pet ownership, improving veterinary services, and increasing demand for long-term glucose monitoring in companion animals.

Who are the major participants shaping the veterinary glucose monitoring devices landscape?

Leading companies in the veterinary glucose monitoring devices market include Zoetis Inc. (United States), IDEXX Laboratories, Inc. (United States), ACON Laboratories, Inc. (United States), i-SENS, Inc. (South Korea), TaiDoc Technology Corporation (Taiwan), Trividia Health, Inc. (United States), UltiMed, Inc. (United States), Allison Medical, Inc. (United States), Teco Diagnostics (United States), Woodley Equipment Company Ltd. (United Kingdom).
Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →